U.S. markets closed
  • S&P Futures

    4,202.75
    -20.25 (-0.48%)
     
  • Dow Futures

    33,854.00
    -163.00 (-0.48%)
     
  • Nasdaq Futures

    13,894.50
    -86.75 (-0.62%)
     
  • Russell 2000 Futures

    2,294.20
    -15.90 (-0.69%)
     
  • Crude Oil

    71.38
    -0.77 (-1.07%)
     
  • Gold

    1,819.20
    -42.20 (-2.27%)
     
  • Silver

    27.15
    -0.67 (-2.40%)
     
  • EUR/USD

    1.2003
    +0.0003 (+0.02%)
     
  • 10-Yr Bond

    1.5690
    +0.0700 (+4.67%)
     
  • Vix

    18.15
    +1.13 (+6.64%)
     
  • GBP/USD

    1.3991
    +0.0005 (+0.03%)
     
  • USD/JPY

    110.6600
    +0.0470 (+0.04%)
     
  • BTC-USD

    38,605.57
    -1,406.36 (-3.51%)
     
  • CMC Crypto 200

    959.82
    -32.65 (-3.29%)
     
  • FTSE 100

    7,184.95
    +12.47 (+0.17%)
     
  • Nikkei 225

    28,972.16
    -318.85 (-1.09%)
     

We're Not Very Worried About Proteomics International Laboratories' (ASX:PIQ) Cash Burn Rate

  • Oops!
    Something went wrong.
    Please try again later.
·4 min read
  • Oops!
    Something went wrong.
    Please try again later.

There's no doubt that money can be made by owning shares of unprofitable businesses. Indeed, Proteomics International Laboratories (ASX:PIQ) stock is up 105% in the last year, providing strong gains for shareholders. But while the successes are well known, investors should not ignore the very many unprofitable companies that simply burn through all their cash and collapse.

In light of its strong share price run, we think now is a good time to investigate how risky Proteomics International Laboratories' cash burn is. In this article, we define cash burn as its annual (negative) free cash flow, which is the amount of money a company spends each year to fund its growth. Let's start with an examination of the business' cash, relative to its cash burn.

Check out our latest analysis for Proteomics International Laboratories

When Might Proteomics International Laboratories Run Out Of Money?

You can calculate a company's cash runway by dividing the amount of cash it has by the rate at which it is spending that cash. As at June 2020, Proteomics International Laboratories had cash of AU$2.4m and no debt. Looking at the last year, the company burnt through AU$1.8m. Therefore, from June 2020 it had roughly 15 months of cash runway. That's not too bad, but it's fair to say the end of the cash runway is in sight, unless cash burn reduces drastically. However, if we extrapolate the company's recent cash burn trend, then it would have a longer cash run way. You can see how its cash balance has changed over time in the image below.

debt-equity-history-analysis
debt-equity-history-analysis

How Well Is Proteomics International Laboratories Growing?

Some investors might find it troubling that Proteomics International Laboratories is actually increasing its cash burn, which is up 7.6% in the last year. To be fair, given that fact it's hardly inspiring to see that the operating revenue was flat year on year. In light of the data above, we're fairly sanguine about the business growth trajectory. Of course, we've only taken a quick look at the stock's growth metrics, here. This graph of historic earnings and revenue shows how Proteomics International Laboratories is building its business over time.

How Hard Would It Be For Proteomics International Laboratories To Raise More Cash For Growth?

Proteomics International Laboratories seems to be in a fairly good position, in terms of cash burn, but we still think it's worthwhile considering how easily it could raise more money if it wanted to. Companies can raise capital through either debt or equity. Commonly, a business will sell new shares in itself to raise cash and drive growth. By looking at a company's cash burn relative to its market capitalisation, we gain insight on how much shareholders would be diluted if the company needed to raise enough cash to cover another year's cash burn.

Since it has a market capitalisation of AU$77m, Proteomics International Laboratories' AU$1.8m in cash burn equates to about 2.4% of its market value. That means it could easily issue a few shares to fund more growth, and might well be in a position to borrow cheaply.

How Risky Is Proteomics International Laboratories' Cash Burn Situation?

Even though its increasing cash burn makes us a little nervous, we are compelled to mention that we thought Proteomics International Laboratories' cash burn relative to its market cap was relatively promising. Cash burning companies are always on the riskier side of things, but after considering all of the factors discussed in this short piece, we're not too worried about its rate of cash burn. Taking a deeper dive, we've spotted 5 warning signs for Proteomics International Laboratories you should be aware of, and 1 of them doesn't sit too well with us.

If you would prefer to check out another company with better fundamentals, then do not miss this free list of interesting companies, that have HIGH return on equity and low debt or this list of stocks which are all forecast to grow.

This article by Simply Wall St is general in nature. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com.